Medicine and Dentistry
Hemodialysis
100%
Lupus Nephritis
77%
End Stage Renal Disease
57%
Systemic Lupus Erythematosus
43%
Acute Kidney Injury
36%
Renal Biopsy
33%
Human Immunodeficiency Virus
32%
Biological Marker
31%
Arterial Stiffness
29%
Cardiovascular Disease
28%
Creatinine
25%
Electrocardiogram
23%
Proteomics
23%
Cardiovascular System
23%
Artery Calcification
21%
Personalized Medicine
21%
Medicine
21%
COVID-19
21%
Biopsy
20%
Infection
19%
Proteinuria
18%
Chronic Kidney Disease
16%
Kidney Injury
16%
Pulse Wave Velocity
16%
Adverse Event
16%
Mycophenolic Acid
16%
Disease
15%
All Cause Mortality
15%
Transcriptomics
14%
Cardiovascular Risk
14%
Diabetes Mellitus
13%
Sudden Cardiac Death
13%
Hazard Ratio
12%
Diabetes
11%
Arrhythmia
10%
Continuous Hemodialysis
10%
Mesangial Proliferative Glomerulonephritis
10%
Magnesium
10%
Osteoprotegerin
10%
Liver Graft
10%
Disease Course
10%
Interleukin 16
10%
Microangiopathy
10%
Lupus Erythematosus
10%
Subdural Hematoma
10%
Sleep Disorder
10%
Fibroblast Growth Factor 23
10%
Vascular Disease
10%
Cancer Risk
10%
Abdominal Obesity
10%
Keyphrases
Lupus Nephritis
67%
Hemodialysis
34%
Incident Hemodialysis Patients
32%
Incident Hemodialysis
27%
Confidence Interval
24%
End-stage Renal Disease
22%
Arterial Calcification
21%
Fibroblast Growth Factor 23 (FGF23)
21%
New Onset
21%
Urine Proteome
21%
Arterial Stiffness
21%
Kidney Biopsy
21%
Recovery Time
21%
Chronic Kidney Disease
18%
Pulse Wave Velocity
18%
Cardiovascular Mortality
16%
Acute Kidney Injury
16%
COVID-19
16%
Mycophenolate Mofetil
16%
All-cause Mortality
15%
End-stage Kidney Disease
15%
Cardiovascular Risk
15%
Systemic Lupus Erythematosus
13%
Clinically Indicated
13%
Hospitalization
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Single-cell Transcriptomics
12%
Single Center
12%
Urinary Biomarkers
12%
Dialysis Patients
11%
Intermittent Hemodialysis
11%
African American
11%
Arrhythmic Risk
11%
Non-associated
11%
Hazard Ratio
10%
Precision Medicine Research
10%
Risk Profile
10%
Hematoma Expansion
10%
Coronavirus Disease (COVID)
10%
Membranous Nephritis
10%
Membranoproliferative Glomerulonephritis
10%
Continuous Veno-venous Hemodialysis
10%
Multi-ethnic
10%
Renal Thrombotic Microangiopathy
10%
Cardiovascular Implications
10%
Functional Outcomes of Sleep Questionnaire
10%
Patient Perspective
10%
Post-dialysis
10%
Individual Design
10%
Transformation Time
10%
